Active Biotech publishes prospectus and certain new financial information included in the prospectus

NOT FOR RELEASE, DISTRIBUTION OR PUBLICATION, DIRECTLY OR INDIRECTLY, IN OR INTO THE UNITED STATES OF AMERICA, AUSTRALIA, JAPAN OR CANADA OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, DISTRIBUTION OR PUBLICATION WOULD BE UNLAWFUL OR REQUIRE REGISTRATION OR ANY OTHER MEASURES BEYOND WHAT IS REQUIRED UNDER SWEDISH LAW

The prospectus relating to Active Biotech AB’s (publ) rights issue has now been published and is available on the company’s website, www.activebiotech.com and on Mangold’s website, www.mangold.se. The prospectus can also be ordered from Active Biotech by telephone [phone].

New financial information included in the prospectus
The prospectus contains certain financial information regarding Active Biotech’s capital structure and net indebtedness as of 31 October 2020 that has not previously been published. The new financial information is presented in the tables below. The information has not been reviewed by the Company’s auditor.

Capitalization

MSEK	31 October 2020
Current debt
Guaranteed	-
Secured	-
Unguaranteed/unsecured	1.3
Total current debt	1.3
Non-current debt
Guaranteed	-
Secured	-
Unguaranteed/unsecured	0.9
Total non-current debt (excluding the current debt as part of the non-current debt)	0.9
Shareholders’ equity
Share capital	0.8
Legal reserve	-
Other reserves	22.3
Total equity	23.1

Net indebtedness